Healthcare distribution service revenue mix compares the portion of McKesson's segment revenue classified as services rather than products. McKesson disclosed that services represented less than 1% of North American Pharmaceutical revenue, about 7% of Oncology & Multispecialty revenue, about 43% of Prescription Technology Solutions revenue, and less than 1% of Medical-Surgical Solutions revenue in fiscal 2026.
Why the mix matters
The disclosure makes the company's internal economics easier to interpret. North American Pharmaceutical and Medical-Surgical Solutions remain overwhelmingly product-oriented on this presentation, while Prescription Technology Solutions has a much larger service component. Oncology & Multispecialty sits between those endpoints.
Investor caution
Service revenue mix is a classification mix, not a gross-margin measure or proof that service-heavy segments are automatically more profitable. McKesson does not present this as a standardized peer KPI, and the underlying service definitions differ by segment. Use it to explain why segment margins can differ, not to normalize competitors.
Primary source: McKesson fiscal 2026 Form 10-K.
Part of the Healthcare Distribution & Services Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- MCKOpen operating-model research →15 of 15 reviewed concepts in Healthcare Distribution & Services EconomicsCore pharmaceutical distribution scale and margin4 of 4 bridge concepts supportedContinue through this bridge:Pharmaceutical Distribution MarginPharmaceutical Distribution Operating ProfitPharmaceutical Distribution RevenueSpecialty care and prescription-technology economics7 of 7 bridge concepts supportedContinue through this bridge:Oncology & Multispecialty MarginOncology & Multispecialty Operating ProfitOncology & Multispecialty RevenuePrescription Technology MarginPrescription Technology Operating ProfitPrescription Technology RevenueMedical-surgical distribution and asset intensity6 of 6 bridge concepts supportedContinue through this bridge:Medical-Surgical MarginMedical-Surgical Operating ProfitMedical-Surgical RevenueSegment D&ASegment Long-Lived Asset Spending
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare healthcare distribution and services stocks
Continue into stock comparison after reviewing segment scale, profitability, service mix, and capital intensity across healthcare distribution and services businesses.
Explore more topics in the Financial Research Encyclopedia.